DU
KLRS

Delphia (USA)’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Delphia (USA)’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-491
Closed -$44K – 436
2022
Q2 		$44K Buy
+491
New +$44K 0.03% 373